Renal angioplasty and stenting under protection: The way for the future?

被引:91
作者
Henry, M
Henry, I
Klonaris, C
Polydorou, A
Rath, P
Lakshmi, G
Rajacopal, S
Hugel, M
机构
[1] Apollo Clin, Int Vasc Inst, Hyderabad, Andhra Pradesh, India
[2] Gen Hosp St Panteleimon, Dept Cardiol, Athens, Greece
[3] Railway Hosp, Dept Cardiol, Madras, Tamil Nadu, India
关键词
renal artery; hypertension; angioplasty; stent; protection devices; renal insufficiency;
D O I
10.1002/ccd.10669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to evaluate the feasibility and safety of renal artery angioplasty and stenting utilizing a distal protection device to reduce the risk of intraprocedural artery embolism and avoid deterioration of the renal function. Fifty-six hypertensive patients (32 men; mean age, 66 +/- 11.8 years; range, 22-87) with atherosclerotic renal artery stenosis (8 bilateral) underwent angioplasty and stenting with distal protection in 65 renal arteries (58 ostial lesions). Five patients had a solitary kidney, 18 a renal insufficiency. The lesion was crossed either with a GuardWire temporary occlusion balloon (n = 38), which was inflated to provide parenchyma protection or with a filter (EPI Filter; n = 26), or with Angioguard (n = 1), which allows a continuous flow. Generated debris was aspirated and analyzed. Blood pressure and serum creatinine levels were followed. Immediate technical success was 100%. All lesions except one were stented, either directly (43 ostial lesions) or after predilatation (22 ostial lesions). Visible debris were aspirated with the Percusurge in all patients or removed with filters in 80% of the patients. Mean particle number and diameter were 98.1 +/- 60.0 per procedure (range, 13-208) and 201.0 +/- 76.0 mum (range, 38-6,206), respectively. Mean renal artery occlusion time was 6.55 +/- 2.46 min (range, 2.29-13.21) with the PercuSurge device. Mean time in situ (filters) was 4.25 +/- 1.12 min. Mean follow-up was 22.6 +/- 17.6 months (range, 1-47). Systolic and diastolic blood pressure declined from 169.0 +/- 15.2 and 104.0 +/- 13.0 mm Hg, respectively, to 149.7 +/- 12.4 and 92.7 +/- 6.7 mm Hg after the procedure. The mean creatinine level remains constant during the follow-up. At 6-month follow-up (45 patients), renal function did not deteriorate in any patient, whereas 8 patients with baseline renal insufficiency improved after the procedure. At 3 years (19 patients), renal function deteriorated only in 1 patient with renal insufficiency and in 1 patient treated for bilateral renal stenosis, one side without protection. These preliminary results suggest the feasibility and safety of distal protection during renal interventions to protect against atheroembolism and to avoid renal function deterioration. This technique's beneficial effects should be evaluated by randomized studies.
引用
收藏
页码:299 / 312
页数:14
相关论文
共 68 条
[61]   PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY VERSUS SURGICAL RECONSTRUCTION OF ATHEROSCLEROTIC RENAL-ARTERY STENOSIS - A PROSPECTIVE RANDOMIZED STUDY [J].
WEIBULL, H ;
BERGQVIST, D ;
BERGENTZ, SE ;
JONSSON, K ;
HULTHEN, L ;
MANHEM, P .
JOURNAL OF VASCULAR SURGERY, 1993, 18 (05) :841-852
[62]  
White CJ, 1998, CATHETER CARDIO DIAG, V45, P9, DOI 10.1002/(SICI)1097-0304(199809)45:1<9::AID-CCD2>3.0.CO
[63]  
2-7
[64]  
WILMS G, 1989, RADIOLOGE, V29, P195
[65]   RENAL-ARTERY STENT PLACEMENT WITH USE OF THE WALLSTENT ENDOPROSTHESIS [J].
WILMS, GE ;
PEENE, PT ;
BAERT, AL ;
NEVELSTEEN, AA ;
SUY, RM ;
VERHAEGHE, RH ;
VERMYLEN, JG ;
FAGARD, RH .
RADIOLOGY, 1991, 179 (02) :457-462
[66]  
ZELLER TH, 2000, ENDOVASCULAR TREATME, P333
[67]   Screening for renal artery stenosis: Is it justified? [J].
Zierler, RE .
MAYO CLINIC PROCEEDINGS, 2002, 77 (04) :307-308
[68]  
Zuccalà A, 1998, J NEPHROL, V11, P318